Ubs Group Ag Biovie Inc. Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
A detailed history of Ubs Group Ag transactions in Biovie Inc. stock. As of the latest transaction made, Ubs Group Ag holds 22,390 shares of BIVI stock, worth $8,956. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,390
Previous 13,456
66.39%
Holding current value
$8,956
Previous $16,000
31.25%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BIVI
# of Institutions
57Shares Held
7MCall Options Held
51.7KPut Options Held
353K-
Altium Capital Management LP New York, NY3.01MShares$1.21 Million0.9% of portfolio
-
Sabby Management, LLC Upper Saddle River, NJ689KShares$275,65412.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA645KShares$257,8300.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE600KShares$239,9582.37% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny347KShares$138,9600.0% of portfolio
About BIOVIE INC.
- Ticker BIVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,165,300
- Market Cap $12.1M
- Description
- BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...